In a recent article by Terpenes and Testing Magazine, Dr. Jason S. Lupoi discusses his interview with Front Range Biosciences' CEO and Co-Founder, Dr. Jonathan Vaught, regarding the company's focus on providing quality assurance and data-driven solutions for farmers. Additionally, Dr. Vaught explains FRB's process of utilizing marker-assisted breeding to target valuable agronomic traits. Read an excerpt from the article below:
"'The collaboration with the Center for Research in Agricultural Genomics involves research with low-THC [tetrahydrocannabinol] cultivars and building breeding and mapping populations to increase the number of markers we can work with, as well as developing basic knowledge of the biochemical systems in the plant,' Dr. Vaught continued. Although the data analysis from the projects is ongoing, FRB has initiated several crosses based on the analyzed data and have improved their ability to 'hunt' for specific phenotypes. In 2020, FRB will be grasping the next rung on their evolutionary ladder by offering a high cannabigerol variety, and they have plans to announce the release of several other minor cannabinoid varieties as well as plants with novel terpene profiles."
Read the full article here.
- Searching for cannabinoid-rich hemp plants? To view our current availability for cannabinoid-rich clones from our Clean Stock® program, as well as our seedlings and feminized seeds, contact our sales team at: email@example.com or complete an order inquiry at: https://www.frontrangebio.com/inquire
- Stay up-to-date with FRB’s current events and information by following our Resources page